HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Shlapobersky Selected Research

Mark Shlapobersky Research Topics

Disease

4Infections
11/2012 - 10/2006
2Herpes Genitalis (Genital Herpes)
11/2012 - 06/2012
1Plasmacytoma
01/2022
1Clinical Deterioration
01/2022
1Rare Diseases (Rare Disease)
01/2022
1Hematologic Diseases (Blood Diseases)
01/2022
1Testicular Neoplasms (Testicular Cancer)
01/2020
1Neoplasms (Cancer)
01/2020
1Skin Diseases (Skin Disease)
11/2012
1Cytomegalovirus Infections (Inclusion Disease)
11/2012
1Herpes Simplex
06/2012
1Human Influenza (Influenza)
10/2009

Drug/Important Bio-Agent (IBA)

4VaccinesIBA
11/2012 - 10/2009
4vaxfectinIBA
11/2012 - 10/2009
3AntigensIBA
01/2020 - 10/2009
2DNA VaccinesIBA
11/2012 - 06/2012
2LipidsIBA
11/2012 - 10/2009
2Proteins (Proteins, Gene)FDA Link
11/2012 - 10/2009
2DNA (Deoxyribonucleic Acid)IBA
11/2012 - 06/2012
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2020
1Neoplasm Antigens (Tumor Antigens)IBA
01/2020
1Therapeutic UsesIBA
11/2012
1glycoprotein D-herpes simplex virus type 2IBA
11/2012
1Glycoproteins (Glycoprotein)IBA
06/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2011
1Horseradish PeroxidaseIBA
02/2011
1LuminolIBA
02/2011
1Cyclin AIBA
10/2006
1Transcription Factors (Transcription Factor)IBA
10/2006

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2022
1Gastrectomy
01/2022
1Immunotherapy
01/2020